Citation Impact
Citing Papers
Neurofascin as a novel target for autoantibody-mediated axonal injury
2007
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Albumin and multiple sclerosis
2016
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution
2004
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood‐brain barrier in the apparent absence of direct astrocytic contact
2003
Progressive multiple sclerosis: pathology and pathogenesis
2012
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
2005 Standout
Leukocyte Diapedesis In Vivo Induces Transient Loss of Tight Junction Protein at the Blood–Retina Barrier
2005
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The cost-effectiveness of total joint arthroplasty: A systematic review of published literature
2012
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
2012
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
2012
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
2007
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
2005
Involvement of ROS in BBB dysfunction
2009
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Tight junction proteins expression and modulation in immune cells and multiple sclerosis
2011
The changing landscape of atherosclerosis
2021 StandoutNature
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
2010
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
2012
New Antithrombotic Drugs
2009
Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation
2005
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Disruption of central nervous system barriers in multiple sclerosis
2010
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Multiple sclerosis
2008 Standout
Systematic meta-review of supported self-management for asthma: a healthcare perspective
2017
Asthma
2017 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Diabetic Retinopathy
2012 Standout
Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
2002
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation
2015
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
The ADAM metalloproteinases
2008
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Atrial fibrillation
2011
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss
2012
Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
2007
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Alveolar macrophages: plasticity in a tissue-specific context
2014
Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid
2008
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease
2005
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
2011
Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort
2011
CNS dendritic cells: Critical participants in CNS inflammation?
2006
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface
2015
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
Amyotrophic lateral sclerosis: A neurovascular disease
2011
Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis
2007
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels
2009
The blood–brain barrier in health and disease
2012
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
2014 Standout
Blood-derived dendritic cells in an acute brain injury
2005
Antithrombotic Therapy for Atrial Fibrillation
2012
Crosstalk between the circadian clock circuitry and the immune system
2013
Neutrophil recruitment and function in health and inflammation
2013 Standout
Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI
2013
Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis
2011
Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
2009
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
2008 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?
2010
Prognostic Indices for Older Adults
2012
Review: Molecular pathogenesis of blood–brain barrier breakdown in acute brain injury
2010
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
2018
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
2009
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Fms-Like Tyrosine Kinase 3 Ligand Recruits Plasmacytoid Dendritic Cells to the Brain
2006
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Multiple Sclerosis
2018 Standout
Dendritic Cells in Multiple Sclerosis Lesions: Maturation Stage, Myelin Uptake, and Interaction With Proliferating T Cells
2006
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Evaluation of inconsistency in networks of interventions
2013
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
2012
Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Circadian Timing in Cancer Treatments
2010
Using Dabigatran in Patients With Stroke
2011
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
2016 Standout
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications
2012
HIV interactions with dendritic cells: has our focus been too narrow?
2006
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Age‐associated changes in the blood‐brain barrier: comparative studies in human and mouse
2017
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
2011
Works of Jonathan Plumb being referenced
Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate
2010
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery
2009
Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis
2007
Identification of Cells Expressing IL-17A and IL-17F in the Lungs of Patients With COPD
2010
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
2012
Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
2008
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
2011
An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study
2004
Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation
2009
Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
2008
The effect of peroxisome proliferator-activated receptor-γ ligands onin vitroandin vivomodels of COPD
2013
Abnormal Endothelial Tight Junctions in Active Lesions and Normal‐appearing White Matter in Multiple Sclerosis
2002
Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis
2005
Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination
2003
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
2012
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective
2011
Abnormal endothelial tight junctions in active lesions and normal‐appearing white matter in multiple sclerosis
2002
CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions
2003
Upregulation of ADAM-17 expression in active lesions in multiple sclerosis
2006
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty
2008
Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter
2006
Circadian Timing in the Lung; A Specific Role for Bronchiolar Epithelial Cells
2008